2008 - Member of the National Academy of Medicine (NAM)
His primary areas of study are Neuroscience, Lithium, Bipolar disorder, Internal medicine and Mood disorders. His studies deal with areas such as Neurotrophin and Monoaminergic as well as Neuroscience. His research integrates issues of Antidepressant, Prefrontal cortex and GSK-3 in his study of Lithium.
His Mood stabilizer and Mania study in the realm of Bipolar disorder connects with subjects such as Genetic heterogeneity. His Internal medicine study combines topics in areas such as Major depressive disorder, Endocrinology and microRNA. He works mostly in the field of Mood disorders, limiting it down to topics relating to Mood and, in certain cases, Drug development, as a part of the same area of interest.
Husseini K. Manji mostly deals with Neuroscience, Internal medicine, Bipolar disorder, Lithium and Endocrinology. His Neuroscience study combines topics from a wide range of disciplines, such as Synaptic plasticity, Signal transduction and Neurotrophin. His work in Internal medicine tackles topics such as Esketamine which are related to areas like Ketamine.
His Bipolar disorder research focuses on subjects like Mood, which are linked to Psychotherapist. His work investigates the relationship between Lithium and topics such as Pharmacology that intersect with problems in Antidepressant. His Endocrinology research incorporates themes from Receptor, G protein, Mechanism of action and Platelet.
Husseini K. Manji spends much of his time researching Neuroscience, Internal medicine, Bipolar disorder, Mood disorders and Endocrinology. His study looks at the relationship between Neuroscience and fields such as Glutamate receptor, as well as how they intersect with chemical problems. His Internal medicine research integrates issues from Esketamine, Treatment-resistant depression and Repeated measures design.
His biological study spans a wide range of topics, including Psychotherapist, Schizophrenia and Mood. The Mood disorders study combines topics in areas such as Major depressive disorder, Pharmacology and MAPK/ERK pathway. His work is dedicated to discovering how Endocrinology, Signal transduction are connected with Inositol and other disciplines.
His primary scientific interests are in Neuroscience, Bipolar disorder, Internal medicine, Lithium and Endocrinology. His work deals with themes such as Synaptic plasticity and AMPA receptor, which intersect with Neuroscience. His Bipolar disorder research is multidisciplinary, incorporating perspectives in Clinical evidence, Mood disorders, Dopamine agent and MAPK/ERK pathway.
His study in Mood disorders is interdisciplinary in nature, drawing from both Major depressive disorder and Ketamine hydrochloride. His research in Internal medicine intersects with topics in Olfaction, Learned helplessness and Sniffing. His Lithium study incorporates themes from Cellular respiration, Cell biology, Mood stabilizer and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche.
Archives of General Psychiatry (2006)
The cellular neurobiology of depression
Husseini K. Manji;Wayne C. Drevets;Dennis S. Charney.
Nature Medicine (2001)
Discovering endophenotypes for major depression.
Gregor Hasler;Wayne C Drevets;Husseini K Manji;Dennis S Charney.
New insights into BDNF function in depression and anxiety
Keri Martinowich;Husseini Manji;Bai Lu.
Nature Neuroscience (2007)
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
Sungho Maeng;Carlos A. Zarate;Jing Du;Robert J. Schloesser.
Biological Psychiatry (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora;Carlos A. Zarate;John H. Krystal;Husseini K. Manji.
Nature Reviews Drug Discovery (2008)
A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg.
Archives of General Psychiatry (2010)
Enhancement of hippocampal neurogenesis by lithium.
Guang Chen;Grazyna Rajkowska;Fu Du;Navid Seraji-Bozorgzad.
Journal of Neurochemistry (2002)
Preclinical models: Status of basic research in depression
Eric J. Nestler;Elizabeth Gould;Husseini Manji.
Biological Psychiatry (2002)
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Husseini K Manji;Jorge A Quiroz;Jonathan Sporn;Jennifer L Payne.
Biological Psychiatry (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: